{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:19:36Z","timestamp":1788956376967,"version":"build-2803163510"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There is partial evidence to support the use of phophodiesterase-5 inhibitor (PDE5-I) for the treatment of premature ejaculation (PE).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We compared on-demand dosing of dapoxetine alone and combined with mirodenafil in subjects with lifelong PE and without erectile dysfunction (ED).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Our prospective, randomized, double-blind, placebo-controlled, multicenter trial enrolled 118 subjects with lifelong PE without ED. PE was diagnosed using D \u00a0iagnostic and\u2005S \u00a0tatistical\u2005M \u00a0anual of\u2005M \u00a0ental\u2005D \u00a0isorders, fourth edition, text revision. Patients were divided into two groups: dapoxetine 30 mg plus placebo (group A, n = 56) and dapoxetine 30 mg plus mirodenafil 50 mg (group B, n = 62).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>During 12 weeks, intravaginal ejaculatory latency time (IELT) and the time from foreplay to beginning intercourse (FTIT) with a stopwatch, and Premature Ejaculation Profile (PEP) were measured. Overall sexual act time (OSAT; sum of FTIT and IELT) was calculated. Any treatment-emergent adverse events (TEAEs) were also recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over 12 weeks, IELT, OSAT, and PEP index score significantly improved in group B compared with group A (increased geometric mean IELT in group A and B = 3.6 and 6.1 minutes, P = 0.026; increased geometric mean OSAT in group A and B = 5.5 and 9.9 minutes, P = 0.012; increased median PEP index score in group A and B = 1.0 and 1.3, P = 0.046). However, there was no significant difference between two groups with respect to improvement of FTIT (P = 0.147). TEAEs did not differ between groups (all P &amp;gt; 0.05), and there was no serious adverse event in any subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Low dose of dapoxetine combined with mirodenafil showed better results in terms of IELT, OSAT, and PEP index score, and similar TEAEs, compared with that of dapoxetine only. Our results support the suggestion that the PDE5-Is have a potential role in the treatment of PE without ED.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12287","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T21:24:54Z","timestamp":1376342694000},"page":"2832-2841","source":"Crossref","is-referenced-by-count":26,"title":["Comparison Between On-Demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients with Lifelong Premature Ejaculation: Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study"],"prefix":"10.1093","volume":"10","author":[{"given":"Won Ki","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Urology, College of Medicine \u00a0 , Chuncheon, , Korea"},{"name":"Hallym Unversity, Chuncheon Sacred Heart Hospital \u00a0 , Chuncheon, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine \u00a0 , Chuncheon, , Korea"},{"name":"Hallym Unversity, Chuncheon Sacred Heart Hospital \u00a0 , Chuncheon, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Tae","family":"Cho","sequence":"additional","affiliation":[{"name":"Kangnam Sacred Heart Hospital , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sung","family":"Lee","sequence":"additional","affiliation":[{"name":"Hangang Sacred Heart Hospital , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Young","family":"Oh","sequence":"additional","affiliation":[{"name":"Hallym University Sacred Heart Hospital , Anyang, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhee","family":"Yoo","sequence":"additional","affiliation":[{"name":"Hallym University Sacred Heart Hospital , Anyang, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seon","family":"Cho","sequence":"additional","affiliation":[{"name":"Hallym University Sacred Heart Hospital , Anyang, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine \u00a0 , Chuncheon, , Korea"},{"name":"Hallym Unversity, Chuncheon Sacred Heart Hospital \u00a0 , Chuncheon, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Yul","family":"Yang","sequence":"additional","affiliation":[{"name":"Kangdong Sacred Heart Hospital , Seoul, , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"2024032602333518200_bib1","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","article-title":"International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"issue":"suppl 4","key":"2024032602333518200_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1743-6109.2011.02451.x","article-title":"An overview of pharmacotherapy in premature ejaculation","volume":"8","author":"Porst","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib3","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1111\/j.1743-6109.2011.02386.x","article-title":"Oral agents for the treatment of premature ejaculation: Review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"2024032602333518200_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/14728220802663549","article-title":"Premature ejaculation: Focus on therapeutic targets","volume":"13","author":"Abdel-Hamid","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"2024032602333518200_bib6","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1743-6109.2011.02628.x","article-title":"Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation: A systematic review and meta-analysis","volume":"9","author":"Asimakopoulos","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"2024032602333518200_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1439-0272.2008.00910.x","article-title":"Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study","volume":"41","author":"Mathers","year":"2009","journal-title":"Andrologia"},{"key":"2024032602333518200_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000112607","article-title":"Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study","volume":"80","author":"Mattos","year":"2008","journal-title":"Urol Int"},{"key":"2024032602333518200_bib10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1464-410X.2010.09646.x","article-title":"The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: A double-blind laboratory setting study","volume":"107","author":"Gokce","year":"2010","journal-title":"BJU Int"},{"key":"2024032602333518200_bib11","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/j.1743-6109.2008.00945.x","article-title":"Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction","volume":"5","author":"Paick","year":"2008","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.ijir.3901420","article-title":"Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors","volume":"18","author":"Dresser","year":"2006","journal-title":"Int J Impot Res"},{"key":"2024032602333518200_bib13","article-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"2024032602333518200_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5534\/wjmh.2013.31.1.70","article-title":"Self-reported prevalence of and attitudes toward premature ejaculation in a community-based study of married couples","volume":"31","author":"Hwang","year":"2013","journal-title":"World J Mens Health"},{"key":"2024032602333518200_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","article-title":"Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function","volume":"54","author":"Cappelleri","year":"1999","journal-title":"Urology"},{"key":"2024032602333518200_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.juro.2006.10.044","article-title":"Correlates to the clinical diagnosis of premature ejaculation: Results from a large observational study of men and their partners","volume":"177","author":"Rosen","year":"2007","journal-title":"J Urol"},{"key":"2024032602333518200_bib17","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1743-6109.2008.00836.x","article-title":"Clinical trial methodology in premature ejaculation observational, interventional and treatment preference studies\u2014Part 1\u2014Defining and selecting the study population","volume":"6","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1464-410X.2008.08041.x","article-title":"The Premature Ejaculation Profile: Validation of self-reported outcome measures for research and practice","volume":"103","author":"Patrick","year":"2009","journal-title":"BJU Int"},{"key":"2024032602333518200_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ijir.2010.34","article-title":"Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation:","volume":"23","author":"Aversa","year":"2011","journal-title":"Int J Impot Res"},{"key":"2024032602333518200_bib20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1743-6109.2007.00696.x","article-title":"Geometric mean IELT and premature ejaculation: Appropriate statistics to avoid overestimation of treatment efficacy","volume":"5","author":"Waldinger","year":"2008","journal-title":"J Sex Med"},{"issue":"suppl 2","key":"2024032602333518200_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2605.2005.00593.x","article-title":"Correlation between ejaculatory and erectile dysfunction","volume":"28","author":"Jannini","year":"2005","journal-title":"Int J Androl"},{"key":"2024032602333518200_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"2024032602333518200_bib23","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1743-6109.2011.02401.x","article-title":"The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation","volume":"8","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/molehr\/gah143","article-title":"Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens","volume":"11","author":"Mancina","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"2024032602333518200_bib25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","article-title":"Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate","volume":"49","author":"Uckert","year":"2006","journal-title":"Eur Urol"},{"key":"2024032602333518200_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bjp.0703657","article-title":"Inhibition of neuroeffector transmission in human vas deferens by sildenafil","volume":"131","author":"Medina","year":"2000","journal-title":"Br J Pharmacol"},{"key":"2024032602333518200_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.urology.2007.02.049","article-title":"Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors","volume":"70","author":"Uckert","year":"2007","journal-title":"Urology"},{"key":"2024032602333518200_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0031-9384(99)00100-6","article-title":"Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS\u2013\/\u2013)","volume":"67","author":"Kriegsfeld","year":"1999","journal-title":"Physiol Behav"},{"key":"2024032602333518200_bib29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0028-3908(94)90054-X","article-title":"The roles of nitric oxide in sexual function of male rats","volume":"33","author":"Hull","year":"1994","journal-title":"Neuropharmacology"},{"key":"2024032602333518200_bib30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1517\/14656566.2010.493174","article-title":"Dapoxetine for premature ejaculation","volume":"11","author":"McMahon","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"2024032602333518200_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2165\/11204750-000000000-00000","article-title":"Dapoxetine: In premature ejaculation","volume":"70","author":"Hoy","year":"2010","journal-title":"Drugs"},{"key":"2024032602333518200_bib32","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/S0022-5347(05)64174-2","article-title":"A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation","volume":"168","author":"Salonia","year":"2002","journal-title":"J Urol"},{"key":"2024032602333518200_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-4295(02)02075-7","article-title":"Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation","volume":"61","author":"Chen","year":"2003","journal-title":"Urology"},{"key":"2024032602333518200_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1442-2042.2007.01606.x","article-title":"Can sildenafil treat primary premature ejaculation: A prospective clinical study","volume":"14","author":"Wang","year":"2007","journal-title":"Int J Urol"},{"key":"2024032602333518200_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000102909","article-title":"Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation","volume":"79","author":"Hosseini","year":"2007","journal-title":"Urol Int"},{"key":"2024032602333518200_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1743-6109.2008.01041.x","article-title":"Women's partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplay","volume":"6","author":"Weiss","year":"2009","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpba.2008.11.004","article-title":"Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats","volume":"49","author":"Lee","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"2024032602333518200_bib38","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/rcm.2943","article-title":"Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK3530) in rats","volume":"21","author":"Lee","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2024032602333518200_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2125.2001.00318.x","article-title":"Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil","volume":"51","author":"Hyland","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"2024032602333518200_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4111\/kju.2011.52.1.1","article-title":"Toward evidence-based genetic research on lifelong premature ejaculation: A critical evaluation of methodology","volume":"52","author":"Waldinger","year":"2011","journal-title":"Korean J Urol"},{"key":"2024032602333518200_bib42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","article-title":"Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine","volume":"7","author":"McMahon","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602333518200_bib44","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515301909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515301909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/11\/2832\/48192778\/jsm_10_11_2832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/11\/2832\/48192778\/jsm_10_11_2832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:35:50Z","timestamp":1711420550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/10\/11\/2832\/6940133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,1]]},"published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12287","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,11]]},"published":{"date-parts":[[2013,11,1]]}}}